Vera Therapeutics, Inc. Contracts & Agreements

48 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter, by and between the Registrant and Jason Carter, dated November 4, 2024
Vera Therapeutics, Inc.
Biotechnology
2025
Vera Therapeutics, Inc. Non-employee Director Compensation Policy, as amended December 9, 2024
Vera Therapeutics, Inc.
Biotechnology
2025
Vera Therapeutics, Inc. 2021 Non-employee Director Compensation Policy, as amended on May 2, 2024
Vera Therapeutics, Inc.
Biotechnology
2025
Vera Therapeutics, Inc. 2024 Inducement Plan, as amended January 28, 2025
Vera Therapeutics, Inc.
Biotechnology
2025
Vera Therapeutics, Inc. 2024 Inducement Plan, as amended
Vera Therapeutics, Inc.
Biotechnology
DE
2024
Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Evercore Group L.L.C. and Cantor Fitzgerald & Co., dated October 29, 2024
Underwriting Agreements
Vera Therapeutics, Inc.
Biotechnology
NY
2024
Offer Letter, by and between the Registrant and David Johnson, dated June 26, 2024
Vera Therapeutics, Inc.
Biotechnology
CA
2024
Offer Letter, by and between the Company and David Johnson, dated June 26, 2024
Vera Therapeutics, Inc.
Biotechnology
CA
2024
Offer Letter, by and between the Registrant and William Turner, dated December 19, 2023
Vera Therapeutics, Inc.
Biotechnology
CA
2024
Offer Letter, by and between the Registrant and Robert Brenner, M.D., dated January 3, 2024
Vera Therapeutics, Inc.
Biotechnology
CA
2024
Vera Therapeutics, Inc. Non-employee Director Compensation Policy, as amended December 6, 2023
Compensation Agreements
Vera Therapeutics, Inc.
Biotechnology
2024
Description of Common Stock of the Registrant
Stock Agreements
Vera Therapeutics, Inc.
Biotechnology
2024
Vera Therapeutics, Inc. 2024 Inducement Plan
Vera Therapeutics, Inc.
Biotechnology
DE
2024
Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Vera Therapeutics, Inc. 2024 Inducement Plan
Stock Agreements
Vera Therapeutics, Inc.
Biotechnology
2024
Form of Restricted Stock Unit Grant Notice and Award Agreement under the Vera Therapeutics, Inc. 2024 Inducement Plan
Stock Agreements
Vera Therapeutics, Inc.
Biotechnology
2024
Separation Agreement by and between the Registrant and Celia Lin, M.D., dated January 3, 2024
Separation Agreements
Vera Therapeutics, Inc.
Biotechnology
CA
2024
Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C., dated January 29, 2024
Underwriting Agreements
Vera Therapeutics, Inc.
Biotechnology
NY
2024
Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C., dated February 1, 2023
Underwriting Agreements
Vera Therapeutics, Inc.
Biotechnology
NY
2023
First Amendment to Loan and Security Agreement, by and between the Registrant and Oxford Finance, LLC, dated November 4, 2022
Loan Agreements
Vera Therapeutics, Inc.
Biotechnology
2022
Amendment to License Agreement, dated September 9, 2022, by and between the Company and Novartis Pharma AG
License Agreements
Vera Therapeutics, Inc.
Biotechnology
2022
Description of Common Stock of the Registrant
Stock Agreements
Vera Therapeutics, Inc.
Biotechnology
2022
Asset Purchase Agreement between the Registrant and Amplyx Pharmaceuticals, Inc. dated December 16, 2021
Purchase Agreements
Vera Therapeutics, Inc.
Biotechnology
NY
2022
Amendment No. 1 to License Agreement between Novartis International Pharmaceutical AG and Amplyx Pharmaceuticals, Inc. dated September 24, 2019
License Agreements
Vera Therapeutics, Inc.
Biotechnology
NY
2022
License Agreement between Novartis International Pharmaceutical AG and Amplyx Pharmaceuticals, Inc. dated August 26, 2019
License Agreements
Vera Therapeutics, Inc.
Biotechnology
NY
2022
Loan and Security Agreement between the Registrant and Oxford Finance LLC, dated December 17, 2021
Loan Agreements
Vera Therapeutics, Inc.
Biotechnology
CA
2022
Form of Underwriting Agreement
Underwriting Agreements
Vera Therapeutics, Inc.
Biotechnology
NY
2022
Offer Letter, by and between the Company and Sean P. Grant, dated May 30, 2021
Vera Therapeutics, Inc.
Biotechnology
CA
2021
Vera Therapeutics, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Vera Therapeutics, Inc.
Biotechnology
DE
2021
Form of Underwriting Agreement
Underwriting Agreements
Vera Therapeutics, Inc.
Biotechnology
NY
2021
Form of Class A Common Stock Certificate
Stock Agreements
Vera Therapeutics, Inc.
Biotechnology
2021
Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Vera Therapeutics, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Vera Therapeutics, Inc.
Biotechnology
2021
Forms of Restricted Stock Unit Grant Notice and Award Agreement under the Vera Therapeutics, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Vera Therapeutics, Inc.
Biotechnology
2021
Vera Therapeutics, Inc. 2021 Employee Stock Purchase Plan
Stock Agreements
Vera Therapeutics, Inc.
Biotechnology
2021
Vera Therapeutics, Inc. 2021 Non-Employee Director Compensation Policy
Compensation Agreements
Vera Therapeutics, Inc.
Biotechnology
2021
Form of Indemnification Agreement by and between the Registrant and its directors and executive officers
Indemnification Agreements
Vera Therapeutics, Inc.
Biotechnology
DE
2021
Amended and Restated Offer Letter by and between the Registrant and Marshall Fordyce, M.D., dated May 7, 2021
Vera Therapeutics, Inc.
Biotechnology
CA
2021
Amended and Restated Offer Letter by and between the Registrant and Joanne Curley, Ph.D., dated May 7, 2021
Vera Therapeutics, Inc.
Biotechnology
CA
2021
Amended and Restated Offer Letter by and between the Registrant and Celia Lin, M.D., dated May 7, 2021
Vera Therapeutics, Inc.
Biotechnology
CA
2021
Second Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated October 29, 2020
Investor Rights Agreements
Vera Therapeutics, Inc.
Biotechnology
DE
2021
License Agreement by and between the Registrant and Ares Trading S.A., dated as of October 29, 2020
License Agreements
Vera Therapeutics, Inc.
Biotechnology
NY
2021
Separation Agreement by and between the Registrant and Allen Ebens, Ph.D., dated September 24, 2020
Separation Agreements
Vera Therapeutics, Inc.
Biotechnology
CA
2021
Offer Letter by and between the Registrant and Allen Ebens, Ph.D., dated July 26, 2018
Vera Therapeutics, Inc.
Biotechnology
CA
2021
Confidential Consulting Agreement by and between the Registrant and FLG Partners, LLC, dated March 15, 2020
Consulting Agreements
Vera Therapeutics, Inc.
Biotechnology
CA
2021
Amendment to Employment Agreement by and between the Registrant and Joanne Curley, Ph.D., dated September 3, 2020
Employment Agreements
Vera Therapeutics, Inc.
Biotechnology
2021
Offer Letter by and between the Registrant and Joanne Curley, Ph.D., dated February 5, 2020
Vera Therapeutics, Inc.
Biotechnology
CA
2021
Amended and Restated Offer Letter by and between the Registrant and Marshall Fordyce, M.D., dated December 22, 2020
Vera Therapeutics, Inc.
Biotechnology
CA
2021
Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the Vera Therapeutics, Inc. 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Vera Therapeutics, Inc.
Biotechnology
2021
Vera Therapeutics, Inc. 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Vera Therapeutics, Inc.
Biotechnology
DE
2021